Friday, September 14, 2012

Neuropsychopharmacology - Table of Contents alert Volume 37 Issue 11


TABLE OF CONTENTS

Volume 37, Issue 11 (October 2012)

In this issue
Original Articles
Corrigendum

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Neuropsychopharmacology Reviews
Highlighting Neurotherapeutics in 2012

Published each January as a special issue of Neuropsychopharmacology, the 2012 edition highlights Neurotherapeutics, with a thorough look at hot topics in this area and in-depth review articles.

Visit www.neuropsychopharmacologyreviews.org and gain access to the full list of reviews.
 

Original Articles

Top

A Randomized, Double-Blind, Placebo-Controlled, Trial of Lamotrigine Therapy in Bipolar Disorder, Depressed or Mixed Phase and Cocaine Dependence

E Sherwood Brown, Prabha Sunderajan, Lisa T Hu, Sharon M Sowell and Thomas J Carmody

Neuropsychopharmacology 2012 37: 2347-2354; advance online publication, June 6, 2012; 10.1038/npp.2012.90

Abstract | Full Text

Chronic Δ9-Tetrahydrocannabinol Exposure Induces a Sensitization of Dopamine D2/3 Receptors in the Mesoaccumbens and Nigrostriatal Systems

Nathalie Ginovart, Benjamin B Tournier, Marcelle Moulin-Sallanon, Thierry Steimer, Vicente Ibanez and Philippe Millet

Neuropsychopharmacology 2012 37: 2355-2367; advance online publication, June 13, 2012; 10.1038/npp.2012.91

Abstract | Full Text

Associations between Cannabinoid Receptor-1 (CNR1) Variation and Hippocampus and Amygdala Volumes in Heavy Cannabis Users

Joseph P Schacht, Kent E Hutchison and Francesca M Filbey

Neuropsychopharmacology 2012 37: 2368-2376; advance online publication, June 6, 2012; 10.1038/npp.2012.92

Abstract | Full Text

Phosphodiesterase 4 Inhibition Impairs Cocaine-Induced Inhibitory Synaptic Plasticity and Conditioned Place Preference

Peng Zhong, Wei Wang, Fei Yu, Maressa Nazari, Xiaojie Liu and Qing-Song Liu

Neuropsychopharmacology 2012 37: 2377-2387; advance online publication, June 20, 2012; 10.1038/npp.2012.93

Abstract | Full Text

Post-Exposure Sleep Deprivation Facilitates Correctly Timed Interactions Between Glucocorticoid and Adrenergic Systems, which Attenuate Traumatic Stress Responses

Shlomi Cohen, Nitsan Kozlovsky, Michael A Matar, Zeev Kaplan, Joseph Zohar and Hagit Cohen

Neuropsychopharmacology 2012 37: 2388-2404; advance online publication, June 20, 2012; 10.1038/npp.2012.94

Abstract | Full Text

Increased Dopamine Receptor Activity in the Nucleus Accumbens Shell Ameliorates Anxiety during Drug Withdrawal

Anna K Radke and Jonathan C Gewirtz

Neuropsychopharmacology 2012 37: 2405-2415; advance online publication, June 13, 2012; 10.1038/npp.2012.97

Abstract | Full Text

Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans

Andrea Dlugos, Emma Childs, Kara L Stuhr, Cecilia J Hillard and Harriet de Wit

Neuropsychopharmacology 2012 37: 2416-2427; advance online publication, July 4, 2012; 10.1038/npp.2012.100

Abstract | Full Text

Increased Glutamate Levels in the Medial Prefrontal Cortex in Patients with Postpartum Depression

Alyssa M McEwen, Denee T A Burgess, Christopher C Hanstock, Peter Seres, Panteha Khalili, Stephen C Newman, Glen B Baker, Nicholas D Mitchell, Janisse Khudabux-Der, Peter S Allen and Jean-Michel LeMelledo

Neuropsychopharmacology 2012 37: 2428-2435; advance online publication, July 18, 2012; 10.1038/npp.2012.101

Abstract | Full Text

Chronic Ethanol Potentiates the Effect of Neuropeptide S in the Basolateral Amygdala and Shows Increased Anxiolytic and Anti-Depressive Effects

Johan Enquist, Madeline Ferwerda, Anuradha Madhavan, Derek Hok and Jennifer L Whistler

Neuropsychopharmacology 2012 37: 2436-2445; advance online publication, June 27, 2012; 10.1038/npp.2012.102

Abstract | Full Text

Methylphenidate Modifies the Motion of the Circadian Clock

Michael C Antle, Hester C van Diepen, Tom Deboer, Pardis Pedram, Rob Rodrigues Pereira and Johanna H Meijer

Neuropsychopharmacology 2012 37: 2446-2455; advance online publication, July 4, 2012; 10.1038/npp.2012.103

Abstract | Full Text

Double Dissociation of the Dorsomedial and Dorsolateral Striatal Control Over the Acquisition and Performance of Cocaine Seeking

Jennifer E Murray, David Belin and Barry J Everitt

Neuropsychopharmacology 2012 37: 2456-2466; advance online publication, June 27, 2012; 10.1038/npp.2012.104

Abstract | Full Text

Blockade of Astrocytic Glutamate Uptake in the Prefrontal Cortex Induces Anhedonia

Catherine S John, Karen L Smith, Ashlee Van'T Veer, Heinrich S Gompf, William A Carlezon, Jr, Bruce M Cohen, Dost Öngür and Anita J Bechtholt-Gompf

Neuropsychopharmacology 2012 37: 2467-2475; advance online publication, June 27, 2012; 10.1038/npp.2012.105

Abstract | Full Text

Transient Inactivation of the Neonatal Ventral Hippocampus Impairs Attentional Set-Shifting Behavior: Reversal with an α7 Nicotinic Agonist

Julie M Brooks, Michelle L Pershing, Morten S Thomsen, Jens D Mikkelsen, Martin Sarter and John P Bruno

Neuropsychopharmacology 2012 37: 2476-2486; advance online publication, July 11, 2012; 10.1038/npp.2012.106

Abstract | Full Text

Effects of Antidepressants, but not Psychopathology, on Cardiac Sympathetic Control: A Longitudinal Study

Carmilla M M Licht, Brenda W J H Penninx and Eco J C de Geus

Neuropsychopharmacology 2012 37: 2487-2495; advance online publication, July 4, 2012; 10.1038/npp.2012.107

Abstract | Full Text

Altered Acquisition and Extinction of Amphetamine-Paired Context Conditioning in Genetic Mouse Models of Altered NMDA Receptor Function

Michael A Benneyworth and Joseph T Coyle

Neuropsychopharmacology 2012 37: 2496-2504; advance online publication, July 4, 2012; 10.1038/npp.2012.108

Abstract | Full Text

Reduced Forebrain Serotonin Transmission is Causally Involved in the Development of Compulsive Cocaine Seeking in Rats

Yann Pelloux, Ruth Dilleen, Daina Economidou, David Theobald and Barry J Everitt

Neuropsychopharmacology 2012 37: 2505-2514; advance online publication, July 4, 2012; 10.1038/npp.2012.111

Abstract | Full Text

Anterior Cingulate Glutamate Levels Related to Clinical Status Following Treatment in First-Episode Schizophrenia

Alice Egerton, Stefan Brugger, Marie Raffin, Gareth J Barker, David J Lythgoe, Philip K McGuire and James M Stone

Neuropsychopharmacology 2012 37: 2515-2521; advance online publication, July 4, 2012; 10.1038/npp.2012.113

Abstract | Full Text

Cortico-Subcortical Neuromodulation Involved in the Amelioration of Prepulse Inhibition Deficits in Dopamine Transporter Knockout Mice

Yosefu Arime, Yoshiyuki Kasahara, F Scott Hall, George R Uhl and Ichiro Sora

Neuropsychopharmacology 2012 37: 2522-2530; advance online publication, July 11, 2012; 10.1038/npp.2012.114

Abstract | Full Text

Differential Roles of GABAA Receptor Subtypes in Benzodiazepine-Induced Enhancement of Brain-Stimulation Reward

Lauren M Reynolds, Elif Engin, Gabriella Tantillo, Hew Mun Lau, John W Muschamp, William A Carlezon, Jr and Uwe Rudolph

Neuropsychopharmacology 2012 37: 2531-2540; advance online publication, July 4, 2012; 10.1038/npp.2012.115

Abstract | Full Text

Variation in the Glucocorticoid Receptor Gene at rs41423247 Moderates the Effect of Prenatal Maternal Psychological Symptoms on Child Cortisol Reactivity and Behavior

Fleur P Velders, Gwen Dieleman, Rolieke AM Cents, Marian J Bakermans-Kranenburg, Vincent WV Jaddoe, Albert Hofman, Marinus H Van IJzendoorn, Frank C Verhulst and Henning Tiemeier

Neuropsychopharmacology 2012 37: 2541-2549; advance online publication, July 11, 2012; 10.1038/npp.2012.118

Abstract | Full Text

Corrigendum

Top

Influence of Cocaine History on the Behavioral Effects of Dopamine D3 Receptor-Selective Compounds in Monkeys

B L Blaylock, R W Gould, A Banala, P Grundt, R R Luedtke, A H Newman and M A Nader

Neuropsychopharmacology 2012 37: 2550; 10.1038/npp.2012.98

Full Text

Advertisement
Neuropsychopharmacology Brainpod: Neurotherapeutics

The brain is a daunting therapeutic challenge. This year's edition of Neuropsychopharmacology Reviews provides an update on treatments for brain disorders ranging from schizophrenia to neurodegeneration. Join Kerri Smith as she talks to Gwenn Smith, editor of this year's volume, about current therapies such as drugs, electrical stimulation and cognitive therapies, and the future of neurotherapeutics in an era of uncertain funding.

Visit www.nature.com/npp/podcast
 

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: